CDSCO
WHO Warns India Must Strengthen Regulations to Prevent Toxic Cough Syrup Deaths
Oct 21, 2025 08:21 pm CST
Despite some regulatory improvements, India still faces significant challenges in preventing toxic cough syrup sales, according to the WHO. Following the deaths of 24 children linked to contaminated medicine containing dangerous levels of diethylene glycol, officials highlight the need for comprehensive testing requirements for both exported and domestically sold pharmaceutical products.
WHO Issues Urgent Global Alert: Toxic Cough Syrups Linked to Child Deaths in India
Oct 14, 2025 01:49 pm CST
The WHO has issued a global health alert against three contaminated cough syrups from India - Coldrif, Respifresh TR, and ReLife - after 25 children died. The products contain toxic Diethylene Glycol and pose life-threatening risks. Authorities have halted production and initiated recalls while warning healthcare professionals worldwide to report any detections of these dangerous medicines.
FAIMA Urges Health Ministry to Form Central Committee to Investigate Fatal Contaminated Cough Syrup Cases
Oct 08, 2025 09:07 pm CST
The Federation of All India Medical Association (FAIMA) has called for a central investigation committee to examine the deaths of over 20 children in Madhya Pradesh and Rajasthan linked to contaminated Coldrif cough syrup. The medical body emphasized the need for nationwide testing of pediatric medications, improved regulatory coordination, and protection of physicians from premature blame while ensuring pharmaceutical safety standards are enforced.
India's Health Ministry Responds to Child Deaths from Contaminated Cough Syrup: Urgent Regulatory Actions and Safety Measures
Oct 05, 2025 11:15 pm CST
Following the deaths of 14 children in Madhya Pradesh and Rajasthan linked to contaminated cough syrup, India's Health Ministry has implemented emergency measures to enhance pharmaceutical oversight. The tainted Coldrif cough syrup contained diethylene glycol, prompting stricter enforcement of manufacturing standards, rational prescription practices for pediatric medications, and improved surveillance systems. Health authorities are warning of criminal negligence in pharmaceutical production while emphasizing that most childhood coughs don't require medication.